Results 161 to 170 of about 33,822 (221)

Efficacy of a new ready-to-use vaccine against PCV-2d and <i>Mycoplasma hyopneumoniae</i> under experimental conditions. [PDF]

open access: yesVet Med (Praha)
Krejci R   +14 more
europepmc   +1 more source

Efficacy of a Novel PCV2d and <i>Mycoplasma hyopneumoniae</i> Combined Vaccine in Piglets with High and Low Levels of PCV2 Maternally Derived Antibodies at Vaccination. [PDF]

open access: yesVaccines (Basel)
Sagrera M   +9 more
europepmc   +1 more source

Exploring the Genetic Diversity of Mycoplasma hyopneumoniae in Pigs with Pneumonia and Pleurisy at Slaughter. [PDF]

open access: yesMicroorganisms
Panneitz AK   +6 more
europepmc   +1 more source

The <i>Mycoplasma hyopneumoniae</i> protein Mhp274 elicits mucosal and systemic immune responses in mice. [PDF]

open access: yesFront Cell Infect Microbiol
Xie M   +6 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Antimicrobial treatment of Mycoplasma hyopneumoniae infections

The Veterinary Journal, 2020
Mycoplasma hyopneumoniae (M. hyopneumoniae) is the primary agent of enzootic pneumonia, a chronic and economically important respiratory disease of pigs. Control and prevention of M. hyopneumoniae infections can be accomplished by optimization of management and housing conditions, and by vaccination.
Dominiek Maes   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy